Research Premium Foundations Stocks Charts & Analysis Economy Opinion Concepts & Tutorials Mutual Funds Fixed Income CM Strategy Wealth PMS
Cracking the Patent Code: Natco’s Winning Formula Natco Pharma, a leader in APIs and niche generics, faces growth challenges post-Revlimid exclusivity in FY26, with semaglutide offering long-term ... Krishna Appala Jan 22, 2025